Skip to main content

Halo Connect’s helping hand for fundraising bid

By 26th February 2019Halo News

We are delighted to have been able to make a valuable £1,500 contribution to a young boy’s bid to receive lifesaving cancer treatment in America.

2-year-old Dylan Alcock, from Staffordshire, was diagnosed with a brain tumour just over a month ago and following neurosurgery at Alder Hey children’s hospital in Liverpool, it was recommended he travel to America to receive ground-breaking focal proton radiotherapy treatment, which isn’t yet available in the UK.

Mum Anna Alcock said: “Dylan has always been a very healthy little boy, until he started complaining of a bad back and temperature, waking up in the night because of it. He was diagnosed with early set tonsillitis but after a week on antibiotics he was still in pain and lethargic.

“After several visits to the emergency doctors he was given an MRI which diagnosed the brain tumour. Some people say that when you receive this kind of news your world stops, ours just started spinning, but as parents we didn’t have time to fall apart, because now it all became about the fight to keep our little boy alive!

“After hearing about the treatment in America, Dylan’s Auntie set up a fundraising page and we are so grateful to the many individuals and organisations who have helped us to exceed our target and enabled us to access the three-month treatment trial. Karl and I are deeply touched by everyone’s generosity and kindness and for putting so much effort into fundraising at such a difficult time for our family.”

After hearing about Dylan’s story and fundraising, staff at Halo Connect pledged £1,500 to the campaign, helping the family to exceed their initial £3,000 target.

Halo Connect Solutions Managing Director Jonathan Walker said: “We were all moved by Dylan’s story and wanted to do what we could to ensure he received the best possible treatment in his pledge to be cancer free. We would like to wish Dylan and his family all the best for their journey to America and look forward to hearing good news about his condition at the end of his treatment.”